Add Company
Join Now

Sapere Bio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sapere Bio's estimated annual revenue is currently $930k per year.(i)
  • Sapere Bio's estimated revenue per employee is $155,000

Employee Data

  • Sapere Bio has 6 Employees.(i)
  • Sapere Bio grew their employee count by 0% last year.

Sapere Bio's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Sapere Bio?

Sapere Bio is a diagnostic company in a clinical stage of development. We measure signatures of aging which are then developed into clinical risk prediction tools to predict patient's risk for adverse events in cardiology, nephrology, oncology, and neurology. Our highly differentiable products address critical and unmet medical need and allow risk, inherent to the patient, to be quantified. Accurate risk stratification before procedures and therapies will improve patients’ quality of life, decrease disability and mortality, and cut healthcare costs. Sapere Bio was co-founded by Dr. Norman Sharpless at the Lineberger Comprehensive Cancer Center at the UNC School of Medicine-Chapel Hill and Dr Natalia Mitin, current CEO of Sapere Bio.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M6-14%N/A
#2
$1.7M110%N/A
#3
$2.6M13-38%N/A
#4
$1.3M150%N/A
#5
$2.3M1550%N/A